News -

NEW SCIENTIFIC POSTER on anti-CD20 ADCC activity.

Check out data comparing the iLite ADCC Activity Assay with another commercial available reporter gene assay for ADCC.

The iLite effector cell line, specific target cells and the homologous target negative control cells can be used for both a potency assay and for the quantification of ADDC activity in clinical studies. Click to view poster...

Related links

Topics

  • Diseases

Categories

  • ilite cell-based assays
  • product
  • knowledge

Contacts

Trine Österbye

VP Biopharma Solutions iLite Cell-based Assays +46 40 53 76 47

Related content

Euro Diagnostica announces launch of a new Product Line - iLite® Assay Ready Cells for determination of ADCC activity

Euro Diagnostica AB announces the launch of the iLite ADCC Activity Assay product line and iLite anti-CD20 ADCC Activity Set. Using iLite ADCC Activity Assays, ADCC can be measured in a straight forward, sensitive and reproducible manner. Assay Ready Cells for determination of ADCC activity of antibodies targeting CD20 will be followed by Target cells for HER2, EGFR and membrane bound TNF-alpha.

Euro Diagnostica merges with Biomonitor – enters the fields of theranostics and personalized medicine

Euro Diagnostica, a leader in diagnostic solutions for autoimmune diseases, has entered into a merger agreement with Biomonitor, a leading company in theranostics and personalized medicine. Biomonitor’s patented cell-based assay platform iLite™, based on reporter gene technology, can both monitor functional drug activity and detect neutralizing antibodies.